1
|
Ceprian M, Juntas-Morales R, Campbell G, Walther-Louvier U, Rivier F, Camu W, Esselin F, Echaniz-Laguna A, Stojkovic T, Bouhour F, Latour P, Tricaud N. The Hexokinase 1 5'-UTR Mutation in Charcot-Marie-Tooth 4G Disease Alters Hexokinase 1 Binding to Voltage-Dependent Anion Channel-1 and Leads to Dysfunctional Mitochondrial Calcium Buffering. Int J Mol Sci 2024; 25:4364. [PMID: 38673950 PMCID: PMC11050395 DOI: 10.3390/ijms25084364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2024] [Revised: 03/31/2024] [Accepted: 04/04/2024] [Indexed: 04/28/2024] Open
Abstract
Demyelinating Charcot-Marie-Tooth 4G (CMT4G) results from a recessive mutation in the 5'UTR region of the Hexokinase 1 (HK1) gene. HK participates in mitochondrial calcium homeostasis by binding to the Voltage-Dependent Anion Channel (VDAC), through its N-terminal porin-binding domain. Our hypothesis is that CMT4G mutation results in a broken interaction between mutant HK1 and VDAC, disturbing mitochondrial calcium homeostasis. We studied a cohort of 25 CMT4G patients recruited in the French gypsy population. The disease was characterized by a childhood onset, an intermediate demyelinating pattern, and a significant phenotype leading to becoming wheelchair-bound by the fifth decade of life. Co-IP and PLA studies indicated a strong decreased interaction between VDAC and HK1 in the patients' PBMCs and sural nerve. We observed that either wild-type HK1 expression or a peptide comprising the 15 aa of the N-terminal wild-type HK1 administration decreased mitochondrial calcium release in HEK293 cells. However, mutated CMT4G HK1 or the 15 aa of the mutated HK1 was unable to block mitochondrial calcium release. Taken together, these data show that the CMT4G-induced modification of the HK1 N-terminus disrupts HK1-VDAC interaction. This alters mitochondrial calcium buffering that has been shown to be critical for myelin sheath maintenance.
Collapse
Affiliation(s)
- Maria Ceprian
- Institute for Neuroscience of Montpellier (INM), University Montpellier, INSERM, 34091 Montpellier, France; (M.C.)
| | - Raul Juntas-Morales
- Clinique du Motoneurone, Explorations Fonctionnelles Neurologiques, Service de Neurologie, Hôpital Universitaire Gui de Chauliac, 34295 Montpellier, France; (R.J.-M.); (W.C.); (F.E.)
- Unidad Neuromuscular, Servicio de Neurologia, Hospital Universitario Vall d’Hebron, 08035 Barcelona, Spain
| | - Graham Campbell
- Institute for Neuroscience of Montpellier (INM), University Montpellier, INSERM, 34091 Montpellier, France; (M.C.)
| | - Ulrike Walther-Louvier
- Service de Neuropediatrie, Hôpital Universitaire Gui de Chauliac, 34295 Montpellier, France; (U.W.-L.); (F.R.)
| | - François Rivier
- Service de Neuropediatrie, Hôpital Universitaire Gui de Chauliac, 34295 Montpellier, France; (U.W.-L.); (F.R.)
| | - William Camu
- Clinique du Motoneurone, Explorations Fonctionnelles Neurologiques, Service de Neurologie, Hôpital Universitaire Gui de Chauliac, 34295 Montpellier, France; (R.J.-M.); (W.C.); (F.E.)
| | - Florence Esselin
- Clinique du Motoneurone, Explorations Fonctionnelles Neurologiques, Service de Neurologie, Hôpital Universitaire Gui de Chauliac, 34295 Montpellier, France; (R.J.-M.); (W.C.); (F.E.)
| | - Andoni Echaniz-Laguna
- AEL, Department of Neurology, Bicetre University Hospital, Paris Saclay University, 94270 Paris, France;
| | - Tanya Stojkovic
- Service de Neurologie, Hôpital Universitaire Pitié-Salpêtrière, 75013 Paris, France;
| | - Françoise Bouhour
- Service de Neurologie, Hôpital Universitaire Lyon, 69500 Lyon, France;
| | - Philippe Latour
- Centre de Biologie Est Biochimie et Biologie Moléculaire, Hospices Civils de Lyon, 69677 Bron, France;
| | - Nicolas Tricaud
- Institute for Neuroscience of Montpellier (INM), University Montpellier, INSERM, 34091 Montpellier, France; (M.C.)
- I-Stem, UEVE/UPS U861, INSERM, AFM, 91100 Corbeil-Essonnes, France
| |
Collapse
|
2
|
Murakami T, Sunada Y. Schwann Cell and the Pathogenesis of Charcot–Marie–Tooth Disease. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2019; 1190:301-321. [DOI: 10.1007/978-981-32-9636-7_19] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
3
|
Kan HW, Hsieh JH, Chien HF, Lin YH, Yeh TY, Chao CC, Hsieh ST. CD40-mediated HIF-1α expression underlying microangiopathy in diabetic nerve pathology. Dis Model Mech 2018; 11:dmm033647. [PMID: 29549140 PMCID: PMC5963861 DOI: 10.1242/dmm.033647] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2018] [Accepted: 03/12/2018] [Indexed: 01/31/2023] Open
Abstract
To understand the pathology and molecular signatures of microangiopathy in diabetic neuropathy, we systemically and quantitatively examined the morphometry of microvascular and nerve pathologies of sural nerves. In the endoneurium of diabetic nerves, prominent microangiopathy was observed, as evidenced by reduced capillary luminal area, increased capillary basement membrane thickness and increased proportion of fibrin(+) blood vessels. Furthermore, capillary basement membrane thickness and the proportion of fibrin(+) blood vessels were correlated with small myelinated fiber density in diabetic nerves. In diabetic nerves, there was also significant macrophage and T cell infiltration, and cluster of differentiation 40 (CD40) expression was increased. The molecular alterations observed were upregulation of hypoxia-inducible factor-1α (HIF-1α), mitogen-activated protein kinase-activated protein kinase 2 (MK2; MAPKAPK2) and phosphatase and tensin homolog (PTEN). In addition, HIF-1α was correlated with small myelinated fiber density and capillary luminal area, while both MK2 and PTEN were correlated with capillary basement membrane thickness. The molecular cascades were further demonstrated and replicated in a cell model of microangiopathy on human umbilical vein endothelial cells (HUVECs) exposed to high-glucose medium by silencing of CD40, PTEN and HIF-1α in HUVECs using shRNA. These data clarified the hierarchy of the molecular cascades, i.e. upregulation of CD40 leading to HIF-1α expression in endothelium and nerve fibers. In conclusion, this study revealed the association of microangiopathy, thrombosis and inflammatory infiltrates with nerve degeneration in diabetic nerves, demonstrating that CD40 is a key molecule for the upregulation of HIF-1α and PTEN underlying the severity of microangiopathy.
Collapse
Affiliation(s)
- Hung-Wei Kan
- Department of Anatomy and Cell Biology, National Taiwan University, Taipei 10051, Taiwan
| | - Jung-Hsien Hsieh
- Department of Anatomy and Cell Biology, National Taiwan University, Taipei 10051, Taiwan
- Department of Surgery, National Taiwan University Hospital, Taipei 10002, Taiwan
| | - Hsiung-Fei Chien
- Department of Anatomy and Cell Biology, National Taiwan University, Taipei 10051, Taiwan
- Department of Surgery, National Taiwan University Hospital, Taipei 10002, Taiwan
| | - Yea-Huey Lin
- Department of Neurology, National Taiwan University Hospital, Taipei 10002, Taiwan
| | - Ti-Yen Yeh
- Department of Anatomy and Cell Biology, National Taiwan University, Taipei 10051, Taiwan
| | - Chi-Chao Chao
- Department of Neurology, National Taiwan University Hospital, Taipei 10002, Taiwan
| | - Sung-Tsang Hsieh
- Department of Anatomy and Cell Biology, National Taiwan University, Taipei 10051, Taiwan
- Department of Neurology, National Taiwan University Hospital, Taipei 10002, Taiwan
- Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei 10051, Taiwan
| |
Collapse
|
4
|
Šafka Brožková D, Haberlová J, Mazanec R, Laštůvková J, Seeman P. HSMNR belongs to the most frequent types of hereditary neuropathy in the Czech Republic and is twice more frequent than HMSNL. Clin Genet 2016; 90:161-5. [PMID: 26822750 DOI: 10.1111/cge.12745] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2015] [Revised: 01/21/2016] [Accepted: 01/25/2016] [Indexed: 11/28/2022]
Abstract
Hereditary motor and sensory neuropathy type Russe (HMSNR), also called CMT4G, is an autosomal recessive inherited peripheral neuropathy (IPN) caused by a founder mutation in the HK1 gene. HMSNR affects only patients with Roma origin, similar to the better known HMSN type Lom clarified earlier. By testing IPN patients with Roma origin, we realized that HMSNR affects surprisingly many patients in the Czech Republic. HMSNR is one of the most frequent types of IPN in this country and appears to be twice more frequent than HMSNL. Pronounced lower limb atrophies and severe deformities often lead to walking inability in even young patients, but hands are usually only mildly affected even after many years of disease duration. The group of 20 patients with HMSNR presented here is the first report about the prevalence of HMSNR from central Europe.
Collapse
Affiliation(s)
- D Šafka Brožková
- DNA laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
| | - J Haberlová
- DNA laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
| | - R Mazanec
- Department of Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
| | - J Laštůvková
- Department of Medical Genetics, Masaryk Hospital, Regional Health Corporation, Ústí nad Labem, Czech Republic
| | - P Seeman
- DNA laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
| |
Collapse
|
5
|
Tournev I. The Meryon Lecture at the 18th Annual Meeting of the Meryon Society Wolfson College, Oxford, UK, 12th September 2014: Neuromuscular disorders in Roma (Gypsies)--collaborative studies, epidemiology, community-based carrier testing program and social activities. Neuromuscul Disord 2015; 26:94-103. [PMID: 26564278 DOI: 10.1016/j.nmd.2015.10.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2015] [Revised: 09/29/2015] [Accepted: 10/06/2015] [Indexed: 02/07/2023]
Affiliation(s)
- Ivailo Tournev
- Department of Neurology, Sofia Medical University, Sofia, Bulgaria; Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria; Ethnic Minorities Health Problems Foundation, Sofia, Bulgaria.
| |
Collapse
|
6
|
A Novel GDAP1 Mutation P78L Responsible for CMT4A Disease in Three Moroccan Families. Can J Neurol Sci 2014; 34:421-6. [DOI: 10.1017/s0317167100007290] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Background:The gene encoding the ganglioside-induced-differentiation-associated protein 1 (GDAP1) has been associated with both axonal and demyelinating neuropathy. Up to date, 25 mutations in the GDAP1 gene have been reported in patients from different origins.Methods:Three Moroccan families with early onset ARCMT1 and autosomal recessive inheritance were genotyped to test linkage to 8q21.3 and their GDAP1 gene coding exons screened for mutations.Results:A novel C233T transversion at codon 78 (P78L) was detected in 6 patients from 3 unrelated families. The mutation was found to be homozygous in two families and compound heterozygous in association with the already reported S194X mutation in one family. The P78L mutation was associated with a common haplotype suggesting a Moroccan founder mutation. The patients had symptoms within the two first years of life and developed common phenotype of CMT4A with evident hoarse-voice in two cases with the longer disease duration.Conclusion:P78L mutation was associated with a common haplotype suggesting a common ancestor.
Collapse
|
7
|
Gabrikova D, Mistrik M, Bernasovska J, Bozikova A, Behulova R, Tothova I, Macekova S. Founder mutations in NDRG1 and HK1 genes are common causes of inherited neuropathies among Roma/Gypsies in Slovakia. J Appl Genet 2013; 54:455-60. [PMID: 23996628 DOI: 10.1007/s13353-013-0168-7] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2013] [Revised: 08/13/2013] [Accepted: 08/20/2013] [Indexed: 11/29/2022]
Abstract
Autosomal recessive forms of Charcot-Marie-Tooth disease (CMT) account for less than 10 % of all CMT cases, but are more frequent in the populations with a high rate of consanguinity. Roma (Gypsies) are a transnational minority with an estimated population of 10 to 14 million, in which a high degree of consanguineous marriages is a generally known fact. Similar to the other genetically isolated founder populations, the Roma harbour a number of unique or rare autosomal recessive disorders, caused by "private" founder mutations. There are three subtypes of autosomal recessive CMT with mutations private to the Roma population: CMT4C, CMT4D and CMT4G. We report on the molecular examination of four families of Roma origin in Slovakia with early-onset demyelinating neuropathy and autosomal recessive inheritance. We detected mutation p.R148X (g.631C>T) in the NDRG1 (NM_006096.3) gene in two families and mutation g.9712G>C in the HK1 (NM_033498) gene in the other two families. These mutations cause CMT4D and CMT4G, respectively. The success of molecular genetic analysis in all families confirms that autosomal recessive forms of CMT caused by mutations on the NDRG1 and HK1 genes are common causes of inherited neuropathies among Slovak Roma. Providing genetic analysis of these genes for patients with Roma origin as a common part of diagnostic procedure would contribute to a better rate of diagnosed cases of demyelinating neuropathy in Slovakia and in other countries with a Roma minority.
Collapse
Affiliation(s)
- Dana Gabrikova
- Department of Biology, Faculty of Humanities and Natural Sciences, University of Presov, Ul. 17. Novembra 1, 08116, Presov, Slovakia,
| | | | | | | | | | | | | |
Collapse
|
8
|
Parman Y, Battaloğlu E. Recessively transmitted predominantly motor neuropathies. HANDBOOK OF CLINICAL NEUROLOGY 2013; 115:847-861. [PMID: 23931818 DOI: 10.1016/b978-0-444-52902-2.00048-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Recessively transmitted predominantly motor neuropathies are rare and show a severe phenotype. They are frequently observed in populations with a high rate of consanguineous marriages. At least 15 genes and six loci have been found to be associated with autosomal recessive CMT (AR-CMT) and X-linked CMT (AR-CMTX) and also distal hereditary motor neuronopathy (AR-dHMN). These disorders are genetically heterogeneous but the clinical phenotype is relatively homogeneous. Distal muscle weakness and atrophy predominating in the lower extremities, diminished or absent deep tendon reflexes, distal sensory loss, and pes cavus are the main clinical features of this disorder with occasional cranial nerve involvement. Although genetic diagnosis of some of subtypes of AR-CMT are now available, rapid advances in the molecular genetics and cell biology show a great complexity. Animal models for the most common subtypes of human AR-CMT disease provide clues for understanding the pathogenesis of CMT and also help to reveal possible treatment strategies of inherited neuropathies. This chapter highlights the clinical features and the recent genetic and biological findings in these disorders based on the current classification.
Collapse
Affiliation(s)
- Yeşim Parman
- Department of Neurology, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey.
| | | |
Collapse
|
9
|
Sevilla T, Martínez-Rubio D, Márquez C, Paradas C, Colomer J, Jaijo T, Millán JM, Palau F, Espinós C. Genetics of the Charcot-Marie-Tooth disease in the Spanish Gypsy population: the hereditary motor and sensory neuropathy-Russe in depth. Clin Genet 2012; 83:565-70. [PMID: 22978647 DOI: 10.1111/cge.12015] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2012] [Revised: 09/10/2012] [Accepted: 09/10/2012] [Indexed: 12/24/2022]
Abstract
Four private mutations responsible for three forms demyelinating of Charcot-Marie-Tooth (CMT) or hereditary motor and sensory neuropathy (HMSN) have been associated with the Gypsy population: the NDRG1 p.R148X in CMT type 4D (CMT4D/HMSN-Lom); p.C737_P738delinsX and p.R1109X mutations in the SH3TC2 gene (CMT4C); and a G>C change in a novel alternative untranslated exon in the HK1 gene causative of CMT4G (CMT4G/HMSN-Russe). Here we address the findings of a genetic study of 29 Gypsy Spanish families with autosomal recessive demyelinating CMT. The most frequent form is CMT4C (57.14%), followed by HMSN-Russe (25%) and HMSN-Lom (17.86%). The relevant frequency of HMSN-Russe has allowed us to investigate in depth the genetics and the associated clinical symptoms of this CMT form. HMSN-Russe probands share the same haplotype confirming that the HK1 g.9712G>C is a founder mutation, which arrived in Spain around the end of the 18th century. The clinical picture of HMSN-Russe is a progressive CMT disorder leading to severe weakness of the lower limbs and prominent distal sensory loss. Motor nerve conduction velocity was in the demyelinating or intermediate range.
Collapse
Affiliation(s)
- T Sevilla
- Department of Neurology, Hospital Universitari i Politècnic La Fe, Valencia, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Charcot–Marie–Tooth diseases. Neurogenetics 2012. [DOI: 10.1017/cbo9781139087711.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
11
|
Espinós C, Calpena E, Martínez-Rubio D, Lupo V. Autosomal Recessive Charcot-Marie-Tooth Neuropathy. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2012; 724:61-75. [DOI: 10.1007/978-1-4614-0653-2_5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
|
12
|
Professor P. K. Thomas: clinician, investigator, editor and leader—a retrospective appreciation. Brain 2011; 134:618-26. [DOI: 10.1093/brain/awq230] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
|
13
|
Sahin-Calapoglu N, Soyoz M, Calapoglu M, Ozcelik N. Genetic study of demyelinating form of autosomal-recessive Charcot-Marie-tooth diseases in a Turkish family. Int J Neurosci 2010; 119:1179-89. [PMID: 19922348 DOI: 10.1080/00207450902869906] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of inherited peripheral motor and sensory neuropathies characterized by distal muscle weakness atrophy predominantly in the lower extremities, diminished or absent deep tendon reflexes, distal sensory loss and skeletal deformities. Mode of inheritance could be either autosomal dominant, autosomal recessive, or X-linked. The autosomal-recessive subgroup of CMT (AR-CMT) neuropathies is heterogeneous as well. To date, nine demyelinating loci have been implicated in CMT4 and seven genes have been identified. It has been screened in this study for the presence of mutations in the coding region of GDAP1 and genetic linkage analyses of CMT4B1, CMT4B2, CMT4C, CMT4D, CMT4E, and CMT4F loci were tested in a Turkish family presenting recessively inherited form of CMT disease characterized by severe motor weakness. We did not find any mutations in GDAP1 and genetic linkage excluded for the six demyelinating genes loci (CMT4B1, CMT4B2, CMT4C, CMT4D, CMT4E, and CMT4F). Our findings indicate that another locus may be associated with AR-CMT disease.
Collapse
Affiliation(s)
- Nilufer Sahin-Calapoglu
- Department of Medical Biology, Suleyman Demirel University, Faculty of Medicine, Isparta, Turkey.
| | | | | | | |
Collapse
|
14
|
Diagnosis of Charcot-Marie-Tooth disease. J Biomed Biotechnol 2009; 2009:985415. [PMID: 19826499 PMCID: PMC2760395 DOI: 10.1155/2009/985415] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2009] [Revised: 06/24/2009] [Accepted: 07/08/2009] [Indexed: 01/30/2023] Open
Abstract
Charcot-Marie-Tooth (CMT) disease or hereditary motor and sensory neuropathy (HMSN) is a genetically heterogeneous group of conditions that affect the peripheral nervous system. The disease is characterized by degeneration or abnormal development of peripheral nerves and exhibits a range of patterns of genetic transmission. In the majority of cases, CMT first appears in infancy, and its manifestations include clumsiness of gait, predominantly distal muscular atrophy of the limbs, and deformity of the feet in the form of foot drop. It can be classified according to the pattern of transmission (autosomal dominant, autosomal recessive, or X linked), according to electrophysiological findings (demyelinating or axonal), or according to the causative mutant gene. The classification of CMT is complex and undergoes constant revision as new genes and mutations are discovered. In this paper, we review the most efficient diagnostic algorithms for the molecular diagnosis of CMT, which are based on clinical and electrophysiological data.
Collapse
|
15
|
Hantke J, Chandler D, King R, Wanders RJA, Angelicheva D, Tournev I, McNamara E, Kwa M, Guergueltcheva V, Kaneva R, Baas F, Kalaydjieva L. A mutation in an alternative untranslated exon of hexokinase 1 associated with hereditary motor and sensory neuropathy -- Russe (HMSNR). Eur J Hum Genet 2009; 17:1606-14. [PMID: 19536174 DOI: 10.1038/ejhg.2009.99] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Hereditary Motor and Sensory Neuropathy -- Russe (HMSNR) is a severe autosomal recessive disorder, identified in the Gypsy population. Our previous studies mapped the gene to 10q22-q23 and refined the gene region to approximately 70 kb. Here we report the comprehensive sequencing analysis and fine mapping of this region, reducing it to approximately 26 kb of fully characterised sequence spanning the upstream exons of Hexokinase 1 (HK1). We identified two sequence variants in complete linkage disequilibrium, a G>C in a novel alternative untranslated exon (AltT2) and a G>A in the adjacent intron, segregating with the disease in affected families and present in the heterozygote state in only 5/790 population controls. Sequence conservation of the AltT2 exon in 16 species with invariable preservation of the G allele at the mutated site, strongly favour the exonic change as the pathogenic mutation. Analysis of the Hk1 upstream region in mouse mRNA from testis and neural tissues showed an abundance of AltT2-containing transcripts generated by extensive, developmentally regulated alternative splicing. Expression is very low compared with ubiquitous Hk1 and all transcripts skip exon1, which encodes the protein domain responsible for binding to the outer mitochondrial membrane, and regulation of energy production and apoptosis. Hexokinase activity measurement and immunohistochemistry of the peripheral nerve showed no difference between patients and controls. The mutational mechanism and functional effects remain unknown and could involve disrupted translational regulation leading to increased anti-apoptotic activity (suggested by the profuse regenerative activity in affected nerves), or impairment of an unknown HK1 function in the peripheral nervous system (PNS).
Collapse
Affiliation(s)
- Janina Hantke
- Laboratory of Molecular Genetics, Western Australian Institute for Medical Research and Centre for Medical Research, University of Western Australia, Perth, Australia
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Angelicheva D, Tournev I, Guergueltcheva V, Mihaylova V, Azmanov DN, Morar B, Radionova M, Smith SJ, Zlatareva D, Stevens JM, Kaneva R, Bojinova V, Carter K, Brown M, Jablensky A, Kalaydjieva L, Sander JW. Partial epilepsy syndrome in a Gypsy family linked to 5q31.3-q32. Epilepsia 2009; 50:1679-88. [PMID: 19400876 DOI: 10.1111/j.1528-1167.2009.02066.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
PURPOSE The restricted genetic diversity and homogeneous molecular basis of Mendelian disorders in isolated founder populations have rarely been explored in epilepsy research. Our long-term goal is to explore the genetic basis of epilepsies in one such population, the Gypsies. The aim of this report is the clinical and genetic characterization of a Gypsy family with a partial epilepsy syndrome. METHODS Clinical information was collected using semistructured interviews with affected subjects and informants. At least one interictal electroencephalography (EEG) recording was performed for each patient and previous data obtained from records. Neuroimaging included structural magnetic resonance imaging (MRI). Linkage and haplotype analysis was performed using the Illumina IVb Linkage Panel, supplemented with highly informative microsatellites in linked regions and Affymetrix SNP 5.0 array data. RESULTS We observed an early-onset partial epilepsy syndrome with seizure semiology strongly suggestive of temporal lobe epilepsy (TLE), with mild intellectual deficit co-occurring in a large proportion of the patients. Psychiatric morbidity was common in the extended pedigree but did not cosegregate with epilepsy. Linkage analysis definitively excluded previously reported loci, and identified a novel locus on 5q31.3-q32 with an logarithm of the odds (LOD) score of 3 corresponding to the expected maximum in this family. DISCUSSION The syndrome can be classified as familial temporal lobe epilepsy (FTLE) or possibly a new syndrome with mild intellectual deficit. The linked 5q region does not contain any ion channel-encoding genes and is thus likely to contribute new knowledge about epilepsy pathogenesis. Identification of the mutation in this family and in additional patients will define the full phenotypic spectrum.
Collapse
Affiliation(s)
- Dora Angelicheva
- Laboratory for Molecular Genetics, Centre for Medical Research and Western Australian Institute for Medical Research, The University of Western Australia, Perth, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Paul E, Cronan R, Weston PJ, Boekelheide K, Sedivy JM, Lee SY, Wiest DL, Resnick MB, Klysik JE. Disruption of Supv3L1 damages the skin and causes sarcopenia, loss of fat, and death. Mamm Genome 2009; 20:92-108. [PMID: 19145458 DOI: 10.1007/s00335-008-9168-z] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2008] [Accepted: 12/03/2008] [Indexed: 01/26/2023]
Abstract
Supv3L1 is a conserved and ubiquitously expressed helicase found in numerous tissues and cell types of many species. In human cells, SUPV3L1 was shown to suppress apoptotic death and sister chromatid exchange, and impair mitochondrial RNA metabolism and protein synthesis. In vitro experiments revealed binding of SUPV3L1 to BLM and WRN proteins, suggesting a role in genome maintenance processes. Disruption of the Supv3L1 gene in the mouse has been reported to be embryonic lethal at early developmental stages. We generated a conditional mouse in which the phenotypes associated with the removal of exon 14 can be tested in a variety of tissues. Disruption mediated by a Mx1 promoter-driven Cre displayed a postnatal growth delay, reduced lifespan, loss of adipose tissue and muscle mass, and severe skin abnormalities manifesting as ichthyosis, thickening of the epidermis, and atrophy of the dermis and subcutaneous tissue. Using a tamoxifen-activatable Esr1/Cre driver, Supv3L1 disruption resulted in growth retardation and aging phenotypes, including loss of adipose tissue and muscle mass, kyphosis, cachexia, and premature death. Many of the abnormalities seen in the Mx1-Cre mice, such as hyperkeratosis characterized by profound scaling of feet and tail, could also be detected in tamoxifen-inducible Cre mice. Conditional ablation of Supv3L1 in keratinocytes confirmed atrophic changes in the skin and ichthyosis-like changes. Together, these data indicate that Supv3L1 is important for the maintenance of the skin barrier. In addition, loss of Supv3L1 function leads to accelerated aging-like phenotypes.
Collapse
Affiliation(s)
- Erin Paul
- Division of Biology and Medicine, Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, 70 Ship St., Providence, RI 02903, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Barisic N, Claeys KG, Sirotković-Skerlev M, Löfgren A, Nelis E, De Jonghe P, Timmerman V. Charcot-Marie-Tooth disease: a clinico-genetic confrontation. Ann Hum Genet 2008; 72:416-41. [PMID: 18215208 DOI: 10.1111/j.1469-1809.2007.00412.x] [Citation(s) in RCA: 116] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Charcot-Marie-Tooth disease (CMT) is the most common neuromuscular disorder. It represents a group of clinically and genetically heterogeneous inherited neuropathies. Here, we review the results of molecular genetic investigations and the clinical and neurophysiological features of the different CMT subtypes. The products of genes associated with CMT phenotypes are important for the neuronal structure maintenance, axonal transport, nerve signal transduction and functions related to the cellular integrity. Identifying the molecular basis of CMT and studying the relevant genes and their functions is important to understand the pathophysiological mechanisms of these neurodegenerative disorders, and the processes involved in the normal development and function of the peripheral nervous system. The results of molecular genetic investigations have impact on the appropriate diagnosis, genetic counselling and possible new therapeutic options for CMT patients.
Collapse
Affiliation(s)
- N Barisic
- Department of Pediatrics, Zagreb University Medical School, Zagreb, Croatia.
| | | | | | | | | | | | | |
Collapse
|
19
|
Reconstructing the Origins and Migrations of Diasporic Populations: The Case of the European Gypsies. AMERICAN ANTHROPOLOGIST 2008. [DOI: 10.1525/aa.2004.106.2.267] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
20
|
Georgiou DM, Nicolaou P, Chitayat D, Koutsou P, Babul-Hirji R, Vajsar J, Murphy J, Christodoulou K. A novel GDAP1 mutation 439delA is associated with autosomal recessive CMT disease. Can J Neurol Sci 2007; 33:311-6. [PMID: 17001820 DOI: 10.1017/s0317167100005199] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND Charcot-Marie-Tooth (CMT) disease is the most common form of inherited motor and sensory neuropathy. Based on neurophysiological and neuropathological criteria CMT has been sub-classified into two main types: demyelinating and axonal. Furthermore, it is genetically heterogeneous with autosomal dominant, autosomal recessive (AR) and X-linked modes of inheritance. Thus far, seven genes have been identified in association with the demyelinating AR-CMT disease. We hereby report our clinical and molecular genetic findings in a consanguineous family with AR-CMT. METHODS Two young sisters with AR-CMT and other non-affected family members were clinically and electrophysiologically evaluated and then molecular genetic investigation was carried out in order to identify the pathogenic mutation. RESULTS Following an initial indication for linkage of the family to the CMT4A locus on chromosome 8, we sequenced the Ganglioside-induced differentiation-associated protein 1 (GDAP1) gene and identified a single nucleotide deletion in exon 3 that is associated with AR-CMT in the family. CONCLUSIONS We identified a novel GDAP1 439delA mutation that is associated with AR-CMT in a consanguineous family of Iranian descent with two affected young girls and a history in other members of the family.
Collapse
Affiliation(s)
- Domna-Maria Georgiou
- Molecular Genetics Department D, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Claramunt R, Sevilla T, Lupo V, Cuesta A, Millán JM, Vílchez JJ, Palau F, Espinós C. The p.R1109X mutation in SH3TC2 gene is predominant in Spanish Gypsies with Charcot-Marie-Tooth disease type 4. Clin Genet 2007; 71:343-9. [PMID: 17470135 DOI: 10.1111/j.1399-0004.2007.00774.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Charcot-Marie-Tooth (CMT) disease type 4 (CMT4) is the name given to autosomal recessive forms of hereditary motor and sensory neuropathy (HMSN). When we began this study, three genes or loci associated with inherited peripheral neuropathies had already been identified in the European Gypsy population: HMSN-Lom (MIM 601455), HMSN-Russe (MIM 605285) and the congenital cataracts facial dysmorphism neuropathy syndrome (MIM 604168). We have carried out genetic analyses in a series of 20 Spanish Gypsy families diagnosed with a demyelinating CMT disease compatible with an autosomal recessive trait. We found the p.R148X mutation in the N-myc downstream-regulated gene 1 gene to be responsible for the HMSN-Lom in four families and also possible linkage to the HMSN-Russe locus in three others. We have also studied the CMT4C locus because of the clinical similarities and showed that in 10 families, the disease is caused by mutations located on the SH3 domain and tetratricopeptide repeats 2 (SH3TC2) gene: p.R1109X in 20 out of 21 chromosomes and p.C737_P738delinsX in only one chromosome. Moreover, the SH3TC2 p.R1109X mutation is associated with a conserved haplotype and, therefore, may be a private founder mutation for the Gypsy population. Estimation of the allelic age revealed that the SH3TC2 p.R1109X mutation may have arisen about 225 years ago, probably as the consequence of a bottleneck.
Collapse
Affiliation(s)
- R Claramunt
- Instituto de Biomedicina, Consejo Superior de Investigaciones Científicas, Valencia, Spain
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Dubourg O, Azzedine H, Verny C, Durosier G, Birouk N, Gouider R, Salih M, Bouhouche A, Thiam A, Grid D, Mayer M, Ruberg M, Tazir M, Brice A, LeGuern E. Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med 2007; 8:75-86. [PMID: 16775368 DOI: 10.1385/nmm:8:1-2:75] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2005] [Revised: 01/03/2006] [Accepted: 01/11/2006] [Indexed: 11/11/2022]
Abstract
Autosomal-recessive forms of Charcot-Marie-Tooth (ARCMT) account for less than 10% of the families in the European CMT population but are more frequent in the Mediterranean basin and the Middle East because of more widespread consanguinity. Until now, demyelinating ARCMT was more extensively studied at the genetic level than the axonal form. Since 1999, the number of localized or identified genes responsible for demyelinating ARCMT has greatly increased. Eight genes, EGR2, GDAP1, KIAA1985, MTMR2, MTMR13, NDRG1, PRX, and CTDP1, have been identified and two new loci mapped to chromosomes 10q23 and 12p11-q13. In this review, we will focus on the particular clinical and/or neuropathological features of the phenotype caused by mutations in each of these genes, which might guide molecular diagnosis.
Collapse
Affiliation(s)
- O Dubourg
- INSERM U679 (ex U289), la Pitié-Salpêtrière Hospital, AP-HP, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Ouvrier R, Geevasingha N, Ryan MM. Autosomal-recessive and X-linked forms of hereditary motor and sensory neuropathy in childhood. Muscle Nerve 2007; 36:131-43. [PMID: 17410579 DOI: 10.1002/mus.20776] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
The hereditary motor and sensory neuropathies (HMSNs, Charcot-Marie-Tooth neuropathies) are the most common degenerative disorders of the peripheral nervous system. In recent years a dramatic expansion has occurred in our understanding of the molecular basis and cell biology of the recessively inherited demyelinating and axonal neuropathies, with delineation of a number of new neuropathies. Mutations in some genes cause a wide variety of clinical, neurophysiologic, and pathologic phenotypes, rendering diagnosis difficult. The X-linked forms of HMSN represent at least 10%-15% of all HMSNs and have an expanded disease spectrum including demyelinating, intermediate, and axonal neuropathies, transient central nervous system (CNS) dysfunction, mental retardation, and hearing loss. This review presents an overview of the recessive and X-linked forms of HMSN observed in childhood, with particular reference to disease phenotype and neurophysiologic and pathologic abnormalities suggestive of specific diagnoses. These findings can be used by the clinician to formulate a differential diagnosis and guide targeted genetic testing.
Collapse
Affiliation(s)
- Robert Ouvrier
- TY Nelson Department of Neurology and Neurosurgery, Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia.
| | | | | |
Collapse
|
24
|
Pareyson D, Scaioli V, Laurà M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8:3-22. [PMID: 16775364 DOI: 10.1385/nmm:8:1-2:3] [Citation(s) in RCA: 115] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2005] [Revised: 12/06/2005] [Accepted: 12/15/2005] [Indexed: 11/11/2022]
Abstract
Charcot-Marie-Tooth disease (CMT) is a genetically heterogeneous group of disorders sharing the same clinical phenotype, characterized by distal limb muscle wasting and weakness, usually with skeletal deformities, distal sensory loss, and abnormalities of deep tendon reflexes. Mutations of genes involved in different functions eventually lead to a length-dependent axonal degeneration, which is the likely basis of the distal predominance of the CMT phenotype. Nerve conduction studies are important for classification, diagnosis, and understanding of pathophysiology. The subdivision into demyelinating CMT1 and axonal CMT2 types was a milestone and is still valid for the majority of patients. However, exceptions to this partition are increasing. Intermediate conduction velocities are often found in males with X-linked CMT (CMTX), and different intermediate CMT types have been identified. Moreover, for some genes, different mutations may result either in demyelinating CMT with slow conduction, or in axonal CMT. Nerve conduction slowing is uniform and diffuse in the most common CMT1A associated with the 17p12 duplication, whereas it is often asymmetric and nonhomogeneous in CMTX, sometimes rendering difficult the differential diagnosis with acquired inflammatory neuropathies. The demyelinating recessive forms, termed CMT4, usually have early onset and run a more severe course than the dominant types. Pure motor CMT types are now classified as distal hereditary motor neuronopathy. The diagnostic approach to the identification of the CMT subtype is complex and cannot be based on the clinical phenotype alone, as different forms are often clinically indistinguishable. However, there are features that may be of help in addressing molecular investigation in a single patient. Late onset, prominent or peculiar sensory manifestations, autonomic nervous system dysfunction, cranial nerve involvement, upper limb predominance, subclinical central nervous system abnormalities, severe scoliosis, early-onset glaucoma, neutropenia are findings helpful for diagnosis.
Collapse
Affiliation(s)
- D Pareyson
- Division of Biochemistry and Genetics, Carlo Besta National Neurological Institute, via Celoria, 11, 20133, Milan, Italy.
| | | | | |
Collapse
|
25
|
Guergueltcheva V, Tournev I, Bojinova V, Hantke J, Litvinenko I, Ishpekova B, Shmarov A, Petrova J, Jordanova A, Kalaydjieva L. Early clinical and electrophysiologic features of the two most common autosomal recessive forms of Charcot-Marie-Tooth disease in the Roma (Gypsies). J Child Neurol 2006; 21:20-5. [PMID: 16551448 DOI: 10.1177/08830738060210010401] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Our recent studies of the genetic epidemiology of neuromuscular disorders in Gypsies in Bulgaria have revealed that two private disorders, hereditary motor and sensory neuropathy type Lom and hereditary motor and sensory neuropathy type Russe, account for most cases of Charcot-Marie-Tooth disease in this population. In this study, we examined the clinical and electrophysiologic manifestations of the two disorders in childhood, aiming to identify the distinctive features that allow early differential diagnosis. The study included 13 patients, aged between 2 and 15 years. The childhood clinical manifestations of both neuropathies were similar, although they tended to be more severe in hereditary motor and sensory neuropathy type Lom. The nerve conduction velocities in hereditary motor and sensory neuropathy type Lom were lower than in hereditary motor and sensory neuropathy type Russe. Brainstem auditory evoked potentials were abnormal in hereditary motor and sensory neuropathy type Lom, even at an early age, and normal in hereditary motor and sensory neuropathy type Russe. Although electrophysiologic data provide a more reliable differentiation than clinical data, the definitive diagnosis should rely on genetic testing. (J Child Neurol 2006;21:20-25).
Collapse
|
26
|
Vallat JM, Tazir M, Magdelaine C, Sturtz F, Grid D. Autosomal-Recessive Charcot-Marie-Tooth Diseases. J Neuropathol Exp Neurol 2005; 64:363-70. [PMID: 15892292 DOI: 10.1093/jnen/64.5.363] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
In certain countries around the Mediterranean basin such as Algeria, which have a high prevalence of consanguineous marriages, autosomal-recessive (AR) inheritance may account for more than 50% of all forms of Charcot-Marie-Tooth (CMT) disease. Like with the dominant forms, it is usual to differentiate the demyelinating forms (CMT 4 corresponding to autosomal-recessive CMT 1 [AR-CMT 1] from the axonal forms [AR-CMT 2]). Genetic analysis of large families with recessive transmission has uncovered novel CMT genotypes (genes: GDAP 1, MTMR 2, MTMR 13, KIAA1985, NDGR1, periaxi, lamin). The clinical and especially the histologic phenotypes often indicate that a specific gene is implicated. We present and discuss microscopic lesions seen on nerve biopsies from patients in a number of consanguineous Algerian families, and we outline the characteristic lesions that would prompt a search for mutations in genes such as MTMR 2, MTMR 13, KIAA1985, periaxin for CMT 4, and lamin for AR-CMT 2. Like with the dominant forms, there are undoubtedly many more mutations of other genes to be discovered.
Collapse
Affiliation(s)
- Jean-Michel Vallat
- Neurology Department, University Hospital, 2 Avenue Martin Luther King, 87042 Limoges, France.
| | | | | | | | | |
Collapse
|
27
|
Acar G, Tanriover G, Demir N, Kayisli UA, Sati GL, Yaba A, Idiman E, Demir R. Ultrastructural and immunohistochemical similarities of two distinct entities; multiple sclerosis and hereditary motor sensory neuropathy. Acta Histochem 2005; 106:363-71. [PMID: 15530551 DOI: 10.1016/j.acthis.2004.08.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2004] [Revised: 08/09/2004] [Accepted: 08/18/2004] [Indexed: 11/15/2022]
Abstract
In the present study, we present the ultrastructural and immunohistochemical properties of the sural nerves of two patients, one of whom was diagnosed as having multiple sclerosis with involvement of the peripheral nervous system (PNS), and the other as having hereditary motor sensory neuropathy type-I with involvement of the central nervous system (CNS). Expression of several extracellular matrix (ECM) proteins (fibronectin, laminin, and collagen type-IV), intermediate filaments (vimentin) and S-100 protein (marker for the axon-Schwann cell interface) was investigated by means of immunohistochemical methods. In addition, the tissue samples were evaluated ultrastructurally. Immunohistochemical staining revealed increased expression of the ECM molecules mentioned above in relation with the sural nerves of the patients. We hypothesize that this enhanced expression is due to Schwann cell-axon interactions. Vimentin expression was different in Schwann cells and S-100 immunostaining was decreased near the Schwann cell-axon interface. Myelin fragmentation, axon vacuolization, onion bulbs, tomoculous formation, axonal degeneration were found to occur. These results suggest that there is active ECM reorganization in the sural nerve of these patients, and some ultrastructural changes are similar in the damaged axonal organization and in Schwann cells although the changes are not completely the same in the two patients. In conclusion, our study demonstrates that there is an association between the demyelinization process in the CNS and the PNS even though they are affected by different mechanisms.
Collapse
Affiliation(s)
- Goksemin Acar
- Department of Neurology, Medical School, Dokuz Eylül University, Izmir, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Kalaydjieva L, Lochmüller H, Tournev I, Baas F, Beres J, Colomer J, Guergueltcheva V, Herrmann R, Karcagi V, King R, Miyata T, Müllner-Eidenböck A, Okuda T, Milic Rasic V, Santos M, Talim B, Vilchez J, Walter M, Urtizberea A, Merlini L. 125th ENMC International Workshop: Neuromuscular disorders in the Roma (Gypsy) population, 23-25 April 2004, Naarden, The Netherlands. Neuromuscul Disord 2004; 15:65-71. [PMID: 15639123 DOI: 10.1016/j.nmd.2004.09.008] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2004] [Indexed: 12/16/2022]
Affiliation(s)
- Luba Kalaydjieva
- Western Australian Institute for Medical Research and Centre for Medical Research, The University of Western Australia, Perth, Australia.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
|
30
|
|
31
|
Hantke J, Rogers T, French L, Tournev I, Guergueltcheva V, Urtizberea JA, Colomer J, Corches A, Lupu C, Merlini L, Thomas PK, Kalaydjieva L. Refined mapping of the HMSNR critical gene region--construction of a high-density integrated genetic and physical map. Neuromuscul Disord 2003; 13:729-36. [PMID: 14561496 DOI: 10.1016/s0960-8966(03)00098-1] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Hereditary motor and sensory neuropathy russe, a form of autosomal recessive Charcot-Marie-Tooth disease, is a rare disorder found in several Roma families from Europe. The gene has been mapped to a 1Mb region on 10q22. Detailed analysis led to the exclusion of 22 candidate genes and the assembly of a high-density genetic map comprising 141 polymorphic markers. Extensive genotyping in an extended sample of affected families resulted in a 10-fold reduction of the critical hereditary motor and sensory neuropathy russe gene region, which is now contained within a single completely sequenced BAC clone. The fact that no sequence variant has been detected in the known genes in the critical region indicates that the hereditary motor and sensory neuropathy russe mutation affects a novel gene that remains to be identified.
Collapse
Affiliation(s)
- Janina Hantke
- Western Australian Institute for Medical Research and Centre for Medical Research, University of Western Australia, Perth, Australia
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Ammar N, Nelis E, Merlini L, Barisić N, Amouri R, Ceuterick C, Martin JJ, Timmerman V, Hentati F, De Jonghe P. Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease. Neuromuscul Disord 2003; 13:720-8. [PMID: 14561495 DOI: 10.1016/s0960-8966(03)00093-2] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Mutations in the ganglioside-induced differentiation-associated protein 1 gene cause either autosomal recessive demyelinating Charcot-Marie-Tooth disease type 4A or autosomal recessive axonal Charcot-Marie-Tooth disease with vocal cord paresis. We sequenced the ganglioside-induced differentiation-associated protein 1 gene in 138 patients from 119 unrelated families diagnosed with either demyelinating or axonal autosomal recessive Charcot-Marie-Tooth disease. We detected six distinct mutant alleles in four families, four of which are novel. Electrophysiological studies show severely slowed motor nerve conduction velocities with severely reduced compound muscle action potentials. However, one patient had a normal conduction velocity in the ulnar nerve. Based on the electrophysiological tests, patients with ganglioside-induced differentiation-associated protein 1 mutations will therefore be classified as either axonal or demyelinating Charcot-Marie-Tooth disease. The neuropathological aspect shows a divergent pattern; nerve biopsies taken from two siblings at the same age and sharing the same ganglioside-induced differentiation-associated protein 1 gene mutation showed a dissimilar severity stage.
Collapse
Affiliation(s)
- Nadia Ammar
- Molecular Genetics Department, Flanders Interuniversity Institute for Biotechnology (VIB), University of Antwerp (UIA), Universiteitsplein 1, B-2610, Antwerp, Belgium
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Gresham D, Morar B, Underhill PA, Passarino G, Lin AA, Wise C, Angelicheva D, Calafell F, Oefner PJ, Shen P, Tournev I, de Pablo R, Kuĉinskas V, Perez-Lezaun A, Marushiakova E, Popov V, Kalaydjieva L. Origins and divergence of the Roma (gypsies). Am J Hum Genet 2001; 69:1314-31. [PMID: 11704928 PMCID: PMC1235543 DOI: 10.1086/324681] [Citation(s) in RCA: 165] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2001] [Accepted: 10/01/2001] [Indexed: 11/03/2022] Open
Abstract
The identification of a growing number of novel Mendelian disorders and private mutations in the Roma (Gypsies) points to their unique genetic heritage. Linguistic evidence suggests that they are of diverse Indian origins. Their social structure within Europe resembles that of the jatis of India, where the endogamous group, often defined by profession, is the primary unit. Genetic studies have reported dramatic differences in the frequencies of mutations and neutral polymorphisms in different Romani populations. However, these studies have not resolved ambiguities regarding the origins and relatedness of Romani populations. In this study, we examine the genetic structure of 14 well-defined Romani populations. Y-chromosome and mtDNA markers of different mutability were analyzed in a total of 275 individuals. Asian Y-chromosome haplogroup VI-68, defined by a mutation at the M82 locus, was present in all 14 populations and accounted for 44.8% of Romani Y chromosomes. Asian mtDNA-haplogroup M was also identified in all Romani populations and accounted for 26.5% of female lineages in the sample. Limited diversity within these two haplogroups, measured by the variation at eight short-tandem-repeat loci for the Y chromosome, and sequencing of the HVS1 for the mtDNA are consistent with a small group of founders splitting from a single ethnic population in the Indian subcontinent. Principal-components analysis and analysis of molecular variance indicate that genetic structure in extant endogamous Romani populations has been shaped by genetic drift and differential admixture and correlates with the migrational history of the Roma in Europe. By contrast, social organization and professional group divisions appear to be the product of a more recent restitution of the caste system of India.
Collapse
Affiliation(s)
- David Gresham
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Bharti Morar
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Peter A. Underhill
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Giuseppe Passarino
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Alice A. Lin
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Cheryl Wise
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Dora Angelicheva
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Francesc Calafell
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Peter J. Oefner
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Peidong Shen
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Ivailo Tournev
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Rosario de Pablo
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Vaidutis Kuĉinskas
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Anna Perez-Lezaun
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Elena Marushiakova
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Vesselin Popov
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| | - Luba Kalaydjieva
- Centre for Human Genetics, Edith Cowan University, and Western Australian Institute for Medical Research, Perth; Department of Genetics, Stanford University School of Medicine, Stanford, CA; Dipartimento di Biologia Cellulare, Università della Calabria, Rende, Italy; Unitat de Biologia Evolutiva, Facultat de Ciencies i de la Vida, Universitat Pompeu Fabra, Barcelona; Stanford Genome Technology Center, Palo Alto, CA; Department of Neurology, Medical University, and Foundation for Health Problems of Ethnic Minorities, and Institute of Ethnology, Bulgarian Academy of Sciences, Sofia; Unidad de Immunologia, Clinica Puerta de Hierro, Madrid; and Human Genetics Centre, Medical Faculty, University of Vilnius, Vilnius, Lithuania
| |
Collapse
|